<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>RSS News Feed for Pharmaceutical Profiles - from Laboratorytalk</title>
    <link>http://www.laboratorytalk.com/news/pha/pha000.html</link>
    <description>Pharmaceutical Profiles news releases on Laboratorytalk</description>
    <language>en-gb</language>
    <copyright>Copyright (C)2008 Pro-Talk Ltd. All rights reserved.</copyright>
    <pubDate>Fri, 11 Jul 2008 08:00:00 UT</pubDate>
    <lastBuildDate>Fri, 11 Jul 2008 08:00:00 UT</lastBuildDate>
    <image>
      <title>Pro-Talk Ltd</title>
      <url>http://www.pro-talk.com/images/protalklogo90.gif</url>
      <link>http://www.pro-talk.com/</link>
      <width>90</width>
      <height>79</height>
    </image>
    <item>
      <title>Attending key industry events in December</title>
      <description>Aerosol Society's Drug Delivery to the Lungs event is the premiere European conference for the presentation of lectures and posters relating to the development of inhalers for respiratory diseases</description>
      <pubDate>Wed, 07 Dec 2005 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha125.html</link>
    </item>
    <item>
      <title>Continued expansion of Asian presence</title>
      <description>Pharmaceutical Profiles is to attend the 26th annual meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT) from 1-3 December 2005 in Beppu, Japan</description>
      <pubDate>Tue, 29 Nov 2005 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha124.html</link>
    </item>
    <item>
      <title>Firm heads to key pharma industry event</title>
      <description>American Association of Pharmaceutical Sciences annual meeting regularly attracts more than 7500 pharmaceutical scientists from all over the world</description>
      <pubDate>Wed, 02 Nov 2005 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha123.html</link>
    </item>
    <item>
      <title>Scintigraphy to visualise in vivo targeting</title>
      <description>Around 30% of drug candidates fail to progress beyond Phase I healthy volunteer studies, and these failures can be attributed mainly to inappropriate human biopharmaceutical properties</description>
      <pubDate>Tue, 14 Jun 2005 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha122.html</link>
    </item>
    <item>
      <title>Career achievement award</title>
      <description>Ian Wilding will receive the 2005 Career Achievement in Oral Drug Delivery Award, sponsored by the Controlled Release Society (CRS) and Eurand</description>
      <pubDate>Wed, 01 Jun 2005 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha121.html</link>
    </item>
    <item>
      <title>Compliance certificates won for Phase I trials</title>
      <description>Prior to the introduction of the EU Clinical Trials Directive in May 2004, there was no regulatory requirement for sites running Phase I healthy volunteer clinical trials to have any formal inspection</description>
      <pubDate>Mon, 14 Feb 2005 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha120.html</link>
    </item>
    <item>
      <title>Another drug development webinar</title>
      <description>Microdosing and human drug absorption studies under the spotlight in live web seminar set for 4 November 2004</description>
      <pubDate>Mon, 01 Nov 2004 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha119.html</link>
    </item>
    <item>
      <title>Enjoying an Indian summer</title>
      <description>'Significant interest' in human drug absorption, microdosing and gastrointestinal studies from the Indian pharmaceutical market</description>
      <pubDate>Wed, 06 Oct 2004 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha118.html</link>
    </item>
    <item>
      <title>Human microdosing points the way forward</title>
      <description>A microdose is 100 times below the level calculated to yield a pharmacological effect or 100 micrograms, whichever is the lower</description>
      <pubDate>Fri, 30 Jul 2004 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha117.html</link>
    </item>
    <item>
      <title>Science is golden for new recruits</title>
      <description>Specialist phase I/IIa CRO Pharmaceutical Profiles is going through one of its busiest ever periods of recruitment as demand for its services continues to increase</description>
      <pubDate>Mon, 28 Jun 2004 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha116.html</link>
    </item>
    <item>
      <title>Early phase drug development innovator wins award</title>
      <description>Ian Wilding, executive chairman of Nottingham, UK-based Pharmaceutical Profiles, celebrates receiving one of the pharmaceutical industry's major US awards</description>
      <pubDate>Wed, 23 Jun 2004 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha115.html</link>
    </item>
    <item>
      <title>More human drug absorption studies in USA</title>
      <description>Rise attributed to better understanding within the major pharmaceutical companies of the ways in which innovative early phase trials can enhance the decision-making process</description>
      <pubDate>Wed, 25 Feb 2004 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha114.html</link>
    </item>
    <item>
      <title>Small doses mean big business</title>
      <description>Partnership aims to accelerate drug development through testing minute quantities in the human body through the ultra-sensitive analytical technique of accelerator mass spectrometry</description>
      <pubDate>Thu, 23 Oct 2003 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha113.html</link>
    </item>
    <item>
      <title>Company reports surge in demand for HDA studies</title>
      <description>Early phase clinical development specialist reports more and more pharmaceutical and biotechnology companies commiting to human drug absorption studies</description>
      <pubDate>Thu, 11 Sep 2003 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha112.html</link>
    </item>
    <item>
      <title>Human absorption studies in live webcast</title>
      <description>The role of human absorption studies in successful product development was examined recently in the first in a series of web-based seminars</description>
      <pubDate>Fri, 25 Jul 2003 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha111.html</link>
    </item>
    <item>
      <title>Controlled Release preview: Pharma Profiles</title>
      <description>Early phase drug development company is set to have a major presence at the most significant event in the drug delivery industry calendar this year</description>
      <pubDate>Thu, 17 Jul 2003 08:00:00 UT</pubDate>
      <category>Pharmaceutical Profiles</category>
      <link>http://www.laboratorytalk.com/news/pha/pha110.html</link>
    </item>
  </channel>
</rss>
